U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940582) titled 'A Research Study Investigating How a New Medicine NNC0721-5186 Works in Women Living With Overweight or Obesity' on Nov. 11.
Brief Summary: This study is being done to look at the safety and how the body takes up, breaks down and removes NNC0721-5186 in people living with overweight or obesity when compared to placebo. In the first 3 dosing groups, NNC0721-5186 will also be compared with semaglutide, a medicine already approved for weight management. Participants will either get NNC0721-5186, semaglutide, or placebo. Which treatment participants get is decided by chance.
Study Start Date: Nov. 13
Study Type: INTERVENTIONAL
Condit...